Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus

  • Betty A. Maddux
  • , Paolo Sbraccia
  • , Shinobu Kumakura
  • , Shlomo Sasson
  • , Jack Youngren
  • , Alexander Fisher
  • , Steven Spencer
  • , Andrew Grupe
  • , William Henzel
  • , Timothy A. Stewart
  • , Gerald M. Reaven
  • , Ira D. Goldfine*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

313 Scopus citations

Abstract

Most patients with non-insulin-dependent diabetes mellitus are resistant to both endogenous and exogenous insulin1. Insulin resistance precedes the onset of this disease2-4, suggesting that it may be an initial abnormality. Insulin-receptor kinase activity is impaired in muscle, fibroblasts and other tissues of many patients with non-insulin-dependent diabetes mellitus5, but abnormalities in the insulin-receptor gene do not appear to be the cause of this decreased kinase activity6, 7. Skin fibroblasts from certain insulin-resistant patients contain an inhibitor of insulin-receptor tyrosine kinase8, 9. Here we show that this inhibitor is a membrane glycoprotein, termed PC-1 (refs 10, 11). We find that PC-1 activity is increased in fibroblasts from seven of nine patients with typical non-insulin-dependent diabetes mellitus. In addition, overexpression of PC-1 in transfected cultured cells reduces insulin-stimulated tyrosine kinase activity. These studies raise the possibility that PC-1 has a role in the insulin resistance of non-insulin-dependent diabetes mellitus.

Original languageEnglish
Pages (from-to)448-451
Number of pages4
JournalNature
Volume373
Issue number6513
DOIs
StatePublished - 2 Feb 1995
Externally publishedYes

Fingerprint

Dive into the research topics of 'Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus'. Together they form a unique fingerprint.

Cite this